Arbutus Biopharma
ABUS
ABUS
99 hedge funds and large institutions have $144M invested in Arbutus Biopharma in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 16 closing their positions.
Holders
99
Holders Change
-12
Holders Change %
-10.81%
% of All Funds
1.58%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
5
Increased
36
Reduced
23
Closed
16
Calls
$1.75M
Puts
$1.1M
Net Calls
+$655K
Net Calls Change
-$553K
Top Buyers
| 1 |
WCM
1
Whitefort Capital Management
New York
|
$24.1M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$9.58M |
| 3 |
3
Hudson Bay Capital Management
Stamford,
Connecticut
|
$8.42M |
| 4 |
CC
4
Centiva Capital
New York
|
$2.18M |
| 5 |
5
BlackRock
New York
|
$20.9M |
